Give And Take As Australia Shakes Up PBS
This article was originally published in PharmAsia News
Executive Summary
The Australian research-based pharma industry is warning that medicine access and corporate investment are at risk from a "last-minute" decision by the health minister to abandon a planned strategic agreement, amid the political passage of a comprehensive package of reforms to the Pharmaceutical Benefits Scheme that include drug price cuts.